<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8D363B26-E92B-436E-8DE6-60AA829BBD54"><gtr:id>8D363B26-E92B-436E-8DE6-60AA829BBD54</gtr:id><gtr:firstName>Emmanuelle</gtr:firstName><gtr:surname>Caron</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F40B6A38-1A7B-4153-A997-485BDCDF9E32"><gtr:id>F40B6A38-1A7B-4153-A997-485BDCDF9E32</gtr:id><gtr:firstName>Rodrigo</gtr:firstName><gtr:otherNames>Andres</gtr:otherNames><gtr:surname>Floto</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ACE18B20-4218-4BD9-A733-D20E6FFAA05A"><gtr:id>ACE18B20-4218-4BD9-A733-D20E6FFAA05A</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>Stuart</gtr:otherNames><gtr:surname>Brown</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801211"><gtr:id>92EECD68-8B46-4582-AAF4-3FF6C85DDAF5</gtr:id><gtr:title>Effects of the Streptococcus pneumoniae capsule on interactions with macrophages and during early lung infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801211</gtr:grantReference><gtr:abstractText>Streptococcus pneumoniae (also known as the pneumococcus) is a bacteria that is a common cause of severe diseases like pneumonia and meningitis. One reason why pneumococcus is able to cause severe infections is that it is coated with a layer of material made of sugars that is called the capsule. This capsule seems to act like a coat of armour, preventing the immune system from killing the bacteria and thereby allowing the bacteria to successfully invade the body. Although it is thought the capsule prevents white cells from getting rid of the pneumococcus, surprisingly little is known on exactly how the capsule disguises or protects the pneumococcus from different aspects of the bodies immune system. The aim of this project is to investigate precisely how the capsule helps the pneumococcus cause disease in particular pneumonia, the commonest severe disease it causes. We will identify which proteins on the white cell surface are prevented from recognising the pneumococcus by the capsule, and what are the consequences of this failure to identify properly the bacteria for the immune response and development of lung infection. As all vaccines against the pneumococcus that are in use at present rely on using the capsule, more detailed information on the functions of the capsule during infection will be helpful. Furthermore, the information obtained may allow the design of new effective therapies against the pneumococcus, and will provide more detailed information on how the pneumococcus is able to cause pneumonia even in previously healthy individuals.</gtr:abstractText><gtr:technicalSummary>The polysaccharide capsule is a major virulence determinant of Streptococcus pneumoniae as well as the target of the vaccines presently in use. The capsule is thought to aid virulence by preventing phagocytosis, but the exact mechanisms involved are surprisingly poorly understood considering the importance of the capsule for S. pneumoniae disease. Furthermore little is known about how the effects of the capsule on interactions with phagocytes can affect disease development. The existing data on the S. pneumoniae capsule and preliminary data from Dr Brown?s laboratory indicate that the capsule can prevent neutrophil phagocytosis by reducing opsonisation of S. pneumoniae with complement. Furthermore, during early lung infection phagocytosis of unencapsulated S. pneumoniae by alveolar macrophages is considerably more efficient than that of encapsulated bacteria. However, phagocytosis can be mediated by interactions between the pathogen and a range of possible phagocyte cell surface receptors, including complement receptors, antibody receptors, lectins, integrins and scavenger receptors, and how the S. pneumoniae capsule affects these interactions with macrophages is poorly defined. We propose to use encapsulated and unencapsulated strains of two S. pneumoniae capsular serotypes to investigate the effect of the capsule on S. pneumoniae interactions with macrophages in more detail. In addition, we will also investigate how the capsule affects S. pneumoniae interactions with the alveolar macrophage in vivo and aids the development of lung infection. By using Dr Brown?s experience in investigating S. pneumoniae immunity and Dr Caron?s expertise in the molecular mechanisms of phagocyosis, we will addresses the hypothesis that the S. pneumoniae capsule increases virulence during the develpment of lung infection mainly by preventing complement opsonisation of the bacteria and thereby indirectly inhibiting phagocytosis by alveolar macrophages. In particular we will use a combination of recent advances in techniques for investigating macrophage cell biology and in the use of animal models to characterise the development of infection to assess the effects of the S. pneumoniae capsule on: (a) the distribution and nature of complement deposition on S. pneumoniae: (b) complement-dependent and -independent interactions of S. pneumoniae with macrophages; (c) which receptors and mechanism(s) are responsible for S. pneumoniae recognition and phagocytosis by macrophages; and (d) how these capsule-dependent effects alter the development of early lung infection. The data obtained will improve our fundamental understanding of the function of the capsule, a major virulence determinant and therapeutic target of S. pneumoniae, and may lead to improved therapies against this important pathogen.</gtr:technicalSummary><gtr:fund><gtr:end>2012-11-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350407</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Pneumococcus and PAR1 mediated inflammation</gtr:description><gtr:id>92EB2459-5B4D-4BD4-B43D-A74A3C8E0AED</gtr:id><gtr:impact>Wellcome PhD training fellowship. Pro-coagulant signalling in Streptococcus pneumoniae induced acute lung injury. Dr R.Jose and J.S.Brown, Professor R.Chambers (approx.. &amp;pound;250,000) 2012-15</gtr:impact><gtr:outcomeId>eCcTv2ZBkAa-1</gtr:outcomeId><gtr:partnerContribution>About equal contributions to design and planning of experimental work</gtr:partnerContribution><gtr:piContribution>Joint research project for a clinical PhD fellow in shared laboratory facilities with my collaborator</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Oral Biology</gtr:department><gtr:description>Protection to Streptococcus pneumoniae by commensal streptococci</gtr:description><gtr:id>28BFE1F9-7F12-4BC8-BB2C-DC0241E3DE79</gtr:id><gtr:impact>none as yet</gtr:impact><gtr:outcomeId>56df0913ee10f5.20074351-1</gtr:outcomeId><gtr:partnerContribution>they led the application</gtr:partnerContribution><gtr:piContribution>I am a coPI on a successful grant application to the Research Council of Norway (award &amp;pound;650,000)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Medicine</gtr:department><gtr:description>Comparative virulence of Streptococcous pneumoniae and Streptococcus mitis</gtr:description><gtr:id>3AEBD4AF-2414-4919-8C3F-8DA29A2CB1E8</gtr:id><gtr:impact>presentation of various abstracts at conferences; poster prize for best poster at Europneumo July 2015
one paper: Rukke HV, Kalluru RS, Repnik U, Gerlini A, Jos&amp;eacute; RJ, Periselneris J, Marshall H, Griffiths G, Oggioni MR, Brown JS, Petersen FC. Protective Role of the Capsule and Impact of Serotype 4 Switching on Streptococcus mitis. Infect Immun. 2014 Sep;82(9):3790-801</gtr:impact><gtr:outcomeId>56df0a9abdfd64.71684732-1</gtr:outcomeId><gtr:partnerContribution>Shared supervision of a PhD student</gtr:partnerContribution><gtr:piContribution>Joint BBSRC PhD fellowship with Dr Laurent Bozec</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Capsule effects on inflammation</gtr:description><gtr:id>371B8538-6172-4F4C-9FD0-AD2C3AF772A1</gtr:id><gtr:impact>MRC PhD training fellowship. Importance of the pro-inflammatory effects of the capsule during invasive Streptococcus pneumoniae infection. Dr J.Persileris, M.Noursadeghi, J.S.Brown (&amp;pound;228,751), 2012-15

Additional grant: Roseberry's Trust project grant. Identification of targets for immunomodulation treatment during severe Streptococcus pneumoniae infections. Prof JS Brown Dr Noursadeghi &amp;pound;30000.</gtr:impact><gtr:outcomeId>EXdFcxjqsKY-1</gtr:outcomeId><gtr:partnerContribution>Support for macrophage biology experiments</gtr:partnerContribution><gtr:piContribution>Joint research project funded by the MRC for a clinical training fellow; the work is largely in my lab</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Welding fumes and lung immunity</gtr:description><gtr:id>C4F696D6-60F3-4944-B63B-BCC321FDABB0</gtr:id><gtr:impact>Colt foundation project grant. Identification of the mechanism for the association between pneumococcal pneumonia and exposure to welding fumes. Prof J. Grigg, J.S.Brown &amp;pound;95,000</gtr:impact><gtr:outcomeId>BfKtSSd8sYa-1</gtr:outcomeId><gtr:partnerContribution>The in vitro assessment; the researcher is based at Queen Mary's</gtr:partnerContribution><gtr:piContribution>Collaborative research - we do mainly the animal models of infection work</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>work experience placements</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6CE81256-E884-4A08-879C-8867AB20EA37</gtr:id><gtr:impact>During 2011 and 2012 we had work experience placements for four school pupils in my laboratory; two of the students have decided to go forward and apply for university courses in the hope of a biomedical research career.
The drop down categories above do not fit this engagement activity but I have had to choose something to enable this to be submitted.

I will be giving a talk to the sixth formers at the school which the four pupils attend in the New Year as part of their invited scientific speakers programme</gtr:impact><gtr:outcomeId>n5ovHNgqKeM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>95000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>The Colt Foundation</gtr:fundingOrg><gtr:id>41D39CD3-009E-4E72-80FD-E944327E1ADB</gtr:id><gtr:outcomeId>abVZqcH7mER</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>650000</gtr:amountPounds><gtr:country>Norway, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Research Council of Norway</gtr:fundingOrg><gtr:id>6DA3436D-ECC0-41A1-B68E-383887B835F3</gtr:id><gtr:outcomeId>56df0b26d07704.14485307</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:id>DB787CDC-4F46-48AB-816A-E43AD0B51F80</gtr:id><gtr:outcomeId>DPbYhPbkHRC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>229000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Training PhD Fellowship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K00168X/1</gtr:fundingRef><gtr:id>891E613E-0DFF-4F05-88CE-639CD56B35AA</gtr:id><gtr:outcomeId>cBEZ35H6qFc</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC PhD fellowship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>194C82F9-5316-4810-9980-CEC58BCC27C2</gtr:id><gtr:outcomeId>56df0bb7d02128.38526972</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical Reference Group membership</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D8F3FDED-8164-453D-9445-EE7EC59FAAF1</gtr:id><gtr:impact>responsible for the design and implementation of national commissioning for subspecialty care for specific areas of respiratory medicine- implemented subspecialty care for three separate conditions across England</gtr:impact><gtr:outcomeId>iwvZAEf22AM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE pneumonia guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C6D82A7E-ED02-4985-B0EC-9A306B0F65E6</gtr:id><gtr:outcomeId>azuLKDJ3NQV</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Thoracic Society short course in lung infection</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9483FEA6-E584-4534-9E9D-2375B807EBEC</gtr:id><gtr:impact>I co-organised and co-chaired (and delivered a lecture) on a British Thoracic Society sponsored short course in lung infection at the annual summer meeting - by educating the audience this should improve provision of care for patients with lung infection</gtr:impact><gtr:outcomeId>YqcWE96DdmD</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lecture to GulfThoracic conference</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>FFCB6D71-3FDE-4F77-82C2-4F16778F2CAE</gtr:id><gtr:impact>I gave two lectures on the care of pneumonia patients at the GulfThoracic conference, Dubai; by educating the healthcare workforce these should improve provision of care for these patients in the Middle East</gtr:impact><gtr:outcomeId>iG3Wy8iYYWL</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal College Regional training day lectures (three in total, a fourth in Oct 2014)</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>90995C4E-5630-4833-ACD4-E2E881B04DD9</gtr:id><gtr:impact>I have given 2012-2013 three lectures to Royal College of Physician regional training days on various aspects of clinical care for patients with pneumonia; a fourth lecture is planned for the national training conference October 2014</gtr:impact><gtr:outcomeId>nZHA8xkf64C</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Bacterial strains, both wild-type and mutant</gtr:description><gtr:id>41790F3F-47E9-48B7-860D-2244343528B1</gtr:id><gtr:impact>research using these strains has contributed to various papers</gtr:impact><gtr:outcomeId>tdr2ePjPcA4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>bacterial strains</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>535519E9-4DD2-4FAB-A3CF-7D996394011D</gtr:id><gtr:title>TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fee2b10c4191f76ee0f698a1eed4e25d"><gtr:id>fee2b10c4191f76ee0f698a1eed4e25d</gtr:id><gtr:otherNames>Tomlinson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>542bc87e192391.49498740</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801211</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>